| Jacek Marian Malik, MD PHD | |
|
540 Snow Hill Rd, Salisbury, MD 21804-6031 | |
| (410) 860-0084 | |
| (410) 860-0411 |
| Full Name | Jacek Marian Malik |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 39 Years |
| Location | 540 Snow Hill Rd, Salisbury, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790758712 | NPI | - | NPPES |
| 187000900 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | D0054048 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peninsula Regional Medical Center | Salisbury, MD | Hospital |
| Atlantic General Hospital | Berlin, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tidalhealth Specialty Care Llc | 7113340845 | 182 |
News Archive
ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema (HAE).
Global regenerative medicine company, Mesoblast Limited, today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack.
Living-donor liver transplant offers numerous advantages over deceased-donor transplant, including better three-year survival rates for patients and lower costs, according to new research from the UPMC Thomas E. Starzl Transplantation Institute and the University of Pittsburgh School of Medicine.
The recent re-emergence of polio in Bangladesh has prompted a vaccination campaign aimed at as many as 18 million children the age of 5.
› Verified 6 days ago
| Entity Name | Tidalhealth Peninsula Regional, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184832040 PECOS PAC ID: 3072509702 Enrollment ID: O20040420001571 |
News Archive
ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema (HAE).
Global regenerative medicine company, Mesoblast Limited, today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack.
Living-donor liver transplant offers numerous advantages over deceased-donor transplant, including better three-year survival rates for patients and lower costs, according to new research from the UPMC Thomas E. Starzl Transplantation Institute and the University of Pittsburgh School of Medicine.
The recent re-emergence of polio in Bangladesh has prompted a vaccination campaign aimed at as many as 18 million children the age of 5.
› Verified 6 days ago
| Entity Name | Tidalhealth Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619504735 PECOS PAC ID: 7113340845 Enrollment ID: O20200714000286 |
News Archive
ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema (HAE).
Global regenerative medicine company, Mesoblast Limited, today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack.
Living-donor liver transplant offers numerous advantages over deceased-donor transplant, including better three-year survival rates for patients and lower costs, according to new research from the UPMC Thomas E. Starzl Transplantation Institute and the University of Pittsburgh School of Medicine.
The recent re-emergence of polio in Bangladesh has prompted a vaccination campaign aimed at as many as 18 million children the age of 5.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacek Marian Malik, MD PHD 100 E Carroll St, Salisbury, MD 21801-5422 Ph: (800) 749-5191 | Jacek Marian Malik, MD PHD 540 Snow Hill Rd, Salisbury, MD 21804-6031 Ph: (410) 860-0084 |
News Archive
ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema (HAE).
Global regenerative medicine company, Mesoblast Limited, today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack.
Living-donor liver transplant offers numerous advantages over deceased-donor transplant, including better three-year survival rates for patients and lower costs, according to new research from the UPMC Thomas E. Starzl Transplantation Institute and the University of Pittsburgh School of Medicine.
The recent re-emergence of polio in Bangladesh has prompted a vaccination campaign aimed at as many as 18 million children the age of 5.
› Verified 6 days ago
Dr. Bothwell Graves Lee, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1630 Woodbrooke Dr, Salisbury, MD 21804 Phone: 410-912-6330 | |
Dr. Curtis Norman Nelson, MD, PHD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 540 Snow Hill Rd, Salisbury, MD 21804 Phone: 410-912-6330 | |
Dr. Larry Roland Shannon Ii, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5771 Royal Mile Blvd, Salisbury, MD 21801 Phone: 410-805-7039 | |
Dr. Sophia Shakur, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 540 Snow Hill Rd, Salisbury, MD 21804 Phone: 410-912-6330 | |
Kofi Kessey, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1630 Woodbrooke Dr, Salisbury, MD 21804 Phone: 410-912-6330 | |
Dr. Muneshwar Devendra Tiwari, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-546-6400 | |
Julius David Zant, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 540 Snow Hill Rd, Salisbury, MD 21804 Phone: 410-860-0084 Fax: 410-860-0411 |